Abstract: Provided is a prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection. A prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A prophylactic and/or therapeutic agent for a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A growth inhibitor for Porphyromonas gingivalis, comprising killed Enterococcus faecalis. An inhibitor for gingipain activity, comprising killed Enterococcus faecalis.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. The prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: The present invention provides a dextrin powder at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. A dextrin powder obtainable by spray drying a dextrin solution, wherein dextrin particles with a length to thickness ratio of 3 or more are contained in a proportion of 3% or more (as based on the number of the particles). A thickener comprising the dextrin powder. A food comprising the dextrin powder.

Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection. The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. The prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet). The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.

Abstract: Provided is a composition for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly. The composition is one for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.

Abstract: The present invention provides dextrin particles at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. Fibrous dextrin particles. A thickener comprising the fibrous dextrin particles. A food comprising the fibrous dextrin particles. A method of preparing fibrous dextrin particles, comprising spray drying a dextrin solution with a viscosity of 100 mPa·s or more.

Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection, The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Disclosed is a composition for reducing the levels or level of glucose, malondialdehyde-modified LDL, homocysteine, and/or C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, malondialdehyde-modified LDL, homocysteine, and C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B12, vitamin B6, and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium, and an antioxidant vitamin.

Abstract: The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet). The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.

Abstract: The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.

Abstract: The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.

Abstract: Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving a nutritional status during cancer chemotherapy. The composition is one for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12, and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.

Abstract: The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.